Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Paul Tlucek (NPI 1982800470)

Field	Value
Entity Type	Individual
Organization	Paul Tlucek
Address	5440 Sw Westgate Dr Ste 217
City	Portland
State	OR
ZIP	97221
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 22, 2007

Payer Source	Total Paid
Medicare	$1.2M
Medicaid	$0

Key Findings

This provider is a retina-focused ophthalmology practice whose Medicare revenue is dominated by intravitreal anti-VEGF therapy: J0178 (820 claims, $568.3K, 47.5% of Medicare revenue), J2778 (1.1K claims, $200.9K, 16.8%), and 67028 (1.2K claims, $121.5K, 10.2%). The precomputed top-3 concentration accounts for 74.5% of the provider's total Medicare revenue, signaling that retinal injection services are the core revenue driver.

The code mix — led by J0178, J2778, and 67028 and supplemented by J2777 (faricimab), J7999 (compounded drugs), and imaging codes such as 92134 — points to an office-based, procedure-heavy retina practice that performs frequent intravitreal injections and associated diagnostic imaging and drug compounding. High volumes of imaging and E/M codes alongside drug administration suggest integrated clinical and procedural workflows rather than a purely surgical or consult-only practice.

Revenue concentration is pronounced: the three leading CPT/HCPCS codes generate 74.5% of Medicare revenue, making the practice heavily reliant on repeat procedural treatments (anti-VEGF injections) for its Medicare case mix. That concentration creates operational sensitivity to changes in drug mix, reimbursement, or utilization patterns for these specific retinal therapies.

From a payer-mix perspective the provider is effectively single-payer at present: Total Medicare revenue is $1.2M while there is no Medicaid billing on file. This indicates limited or no Medicaid footprint in the public-payer mix and suggests Medicare performance will dominate any payer-contracting or utilization analyses.

Competitive standing is mixed by code: the provider’s J0178 volume ranks #1486 of 3204 (54th percentile) and J2778 ranks #395 of 1208 (67th percentile), both characterized as typical, unremarkable national volumes for those drugs; 67028 ranks #1097 of 4255 (74th percentile), indicating modestly higher-than-average procedural activity for vitreous injections. At the same time, several services show notably above-typical national volume—99213 ranks in the 98th percentile (#9853 of 457151) and 92134 ranks in the 95th percentile (#1359 of 26868), while J7999 is also at the 95th percentile (#64 of 1333)—consistent with a practice that generates both high E/M and imaging throughput in addition to drug administration.

There are distinct statistical contrasts within the drug mix: J2777 (faricimab) produces $106.1K (8.9% of Medicare revenue) but ranks in the 15th percentile nationally (#1732 of 2039) and is labeled as typical, unremarkable for its volume, indicating comparatively low adoption or billing of this newer anti-VEGF among peers. Conversely, the provider’s high percentile placement on J7999 (95th) suggests an unusually high use of compounded drugs relative to national peers, which may reflect specific treatment choices or in-office compounding activity.

The provider has an established enrollment history, with the NPI enumerated on 2007-06-22 (~19 years ago), supporting an interpretation of a stable, mature practice likely operating with an established referral and follow-up population that sustains recurrent injection-based care. This tenure combined with concentrated injection revenue and high-volume E/M and imaging services is consistent with a long-standing retina clinic model focused on chronic retinal disease management.

Operationally, the raw claim counts reinforce a throughput-focused model: 820 claims for J0178, 1.1K for J2778, and 1.2K for 67028 demonstrate frequent procedural encounters rather than sporadic surgical episodes. For payers and network planners, this profile implies predictable, recurring service utilization patterns centered on intravitreal injections and associated diagnostics, which is relevant for capacity planning, drug budget impact, and prior-authorization strategies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	820	$690	$568.3K
J2778	Injection, ranibizumab, 0.1 mg	1,120	$180	$200.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,230	$100	$121.5K
J2777	Injection, faricimab‑svoa, 0.1 mg	3,660	$30	$106.1K
J7999	Compounded drug, not otherwise classified	850	$70	$61.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	830	$70	$54.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,670	$30	$51.6K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	120	$130	$15.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	50	$90	$4.9K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	40	$110	$4.7K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

Paul Tlucek — 4 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	32	60	840	$680	$623.7K
J2777	33	30	10,050	$30	$527.6K
J2778	2	20	400	$180	$87.8K
67028	16	70	580	$90	$72.3K
J7999	3	50	270	$70	$23.4K
92235	21	30	60	$100	$11.1K
99214	3,816	6,070	80	$70	$10.3K
92134	20	390	80	$30	$8.1K
99213	45	5,480	60	$50	$5.7K
99204	120	2,750	30	$110	$4.4K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with Paul Tlucek, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Thomas Buroker	IA	Medical Oncology Physician	$9.4M	$0
Kyle Alliman	IA	Ophthalmology Physician	$8.7M	$0
Alex Kartvelishvili	IA	Ophthalmology Physician	$8.1M	$0
Paul Boeke	IA	Ophthalmology Physician	$7.1M	$0
Austin Strohbehn	IA	Retina Specialist (Ophthalmology) Physician	$5.8M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Robert Behrens	IA	Medical Oncology Physician	$5.2M	$0
Matthew Mcknight	IA	Foot & Ankle Surgery Podiatrist	$4.7M	$23.5K
James Singer	IA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Christopher Haupert	IA	Retina Specialist (Ophthalmology) Physician	$3.9M	$0

Nearby Providers

Other providers in the same ZIP code as Paul Tlucek, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lifeworks Nw	OR	Mental Health Counselor	$0	$57.6M
Lifeworks Northwest	OR	Addiction (Substance Use Disorder) Counselor	$0	$14.4M
Retina Northwest P.C.	OR	Ophthalmology Physician	$0	$1.8M
Michael Lee	OR	Retina Specialist (Ophthalmology) Physician	$1.7M	$0
Wenlan Zhang	OR	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Harpal Sandhu	OR	Retina Specialist (Ophthalmology) Physician	$1.4M	$4.5K
Apurva Patel	OR	Retina Specialist (Ophthalmology) Physician	$1.2M	$0
Janani Singaravelu	OR	Ophthalmology Physician	$35.1K	$0

Paul Tlucek — Billing Profile & Reimbursement Data

Sign up for Paul Tlucek — Billing Profile & Reimbursement Data policy alerts

Paul Tlucek — Billing Profile & Reimbursement Data

Sign up for Paul Tlucek — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References